Rubinstein Julie
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1780664. Latest Form 4 filed Oct 26, 2026.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Adaptive Biotechnologies CorpADPT | President and COO, Officer | 12 | 2026-10-22 | 2026-10-26 |
Transactions: 12
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-26 | Adaptive Biotechnologies CorpPresident and COO, Officer | Option exerciseStock Option (right to buy) | 11,881 | $0.00 | $0 | Form 4 |
| 2026-10-26 | Adaptive Biotechnologies CorpPresident and COO, Officer | Sale | 3,378 | $26.30 | $88.8k | Form 4 |
| 2026-10-26 | Adaptive Biotechnologies CorpPresident and COO, Officer | Sale | 8,503 | $25.94 | $220.6k | Form 4 |
| 2026-10-26 | Adaptive Biotechnologies CorpPresident and COO, Officer | Option exercise | 11,881 | $12.14 | $144.2k | Form 4 |
| 2026-10-23 | Adaptive Biotechnologies CorpPresident and COO, Officer | Option exerciseStock Option (right to buy) | 11,881 | $0.00 | $0 | Form 4 |
| 2026-10-23 | Adaptive Biotechnologies CorpPresident and COO, Officer | Sale | 7,381 | $25.28 | $186.6k | Form 4 |
| 2026-10-23 | Adaptive Biotechnologies CorpPresident and COO, Officer | Sale | 4,500 | $24.50 | $110.3k | Form 4 |
| 2026-10-23 | Adaptive Biotechnologies CorpPresident and COO, Officer | Option exercise | 11,881 | $12.14 | $144.2k | Form 4 |
| 2026-10-22 | Adaptive Biotechnologies CorpPresident and COO, Officer | Option exerciseStock Option (right to buy) | 11,881 | $0.00 | $0 | Form 4 |
| 2026-10-22 | Adaptive Biotechnologies CorpPresident and COO, Officer | Sale | 1,700 | $25.29 | $43.0k | Form 4 |
| 2026-10-22 | Adaptive Biotechnologies CorpPresident and COO, Officer | Sale | 10,181 | $24.38 | $248.2k | Form 4 |
| 2026-10-22 | Adaptive Biotechnologies CorpPresident and COO, Officer | Option exercise | 11,881 | $12.14 | $144.2k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 11:49 ET. Listed shows no prices and gives no investment advice.